Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,618.00p
   
  • Change Today:
      11.00p
  • 52 Week High: 1,851.00p
  • 52 Week Low: 1,191.00p
  • Currency: UK Pounds
  • Shares Issued: 208.75m
  • Volume: 7,849
  • Market Cap: £3,377.54m
  • RiskGrade: 125
  • Beta: 0.00

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Key Personnel

CEO: Said Darwazah
Chairman: Victoria Hull
Deputy CEO: Khalid Nabilsi
Executive Vice Chairman: Mazen Darwazah
Independent Non-Executive Director: Cynthia Schwalm
Independent Non-Executive Director: Laura Balan Balan
Independent Non-Executive Director: Deneen Vojta
Independent Non-Executive Director: Tobias Hestler
Senior Independent Director: Douglas Hurt
Non-Executive Dir: Ali Al-Husry

Contact Details

Address: 10 Portman Square, London, United Kingdom, W1H 6AZ
Phone: +44 (0)20 7399 2760
Fax: +44 (0)20 7399 2761
Website: http://www.hikma.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 250, FTSE 350, FTSE All-Share
Overseas Listings: BATSLON:HIKL
ISIN: GB00B0LCW083

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,618.00p
Change Today 11.00p
% Change 0.68 %
52 Week High 1,851.00p
52 Week Low 1,191.00p
Volume 7,849
Shares Issued 208.75m
Market Cap £3,377.54m
Beta 0.00
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
80.94% below the market average80.94% below the market average80.94% below the market average80.94% below the market average80.94% below the market average
44.19% below the sector average44.19% below the sector average44.19% below the sector average44.19% below the sector average44.19% below the sector average
Income
62.33% above the market average62.33% above the market average62.33% above the market average62.33% above the market average62.33% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
35.40% above the market average35.40% above the market average35.40% above the market average35.40% above the market average35.40% above the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average

What The Brokers Say

Strong Buy 7
Buy 2
Neutral 1
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Interim Final
Ex-Div 13-Aug-26 19-Mar-26
Paid 17-Sep-26 30-Apr-26
Amount 38.00¢ 48.00¢

Trades for 09-Oct-2026

Time Volume / Share Price
09:14 22 @ 1,618.00p
09:14 30 @ 1,618.00p
09:14 29 @ 1,619.00p
09:14 24 @ 1,619.00p
09:14 5 @ 1,619.00p

HIK Key Personnel

CEO Said Darwazah
Chair Victoria Hull

Top of Page